Moreover, survival analysis of the effect of UCHL1 expression in ER+ breast cancer patients with tamoxifen treatment indicated that high expression of UCHL1 was significantly associated with poor prognosis in patients with breast cancer [41]. The gene discussed is UCHL1; the disease is breast carcinoma.